Delving into the Latest Updates on Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center) with Synapse

Overview

Basic Info

Drug Type

Mesenchymal stem cell therapy

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Congenital DisordersSkin and Musculoskeletal DiseasesUrogenital Diseases+ [1]

Active Indication

Nephritis, Hereditary

Inactive Indication-

Originator Organization

Guangzhou Women & Childrens Medical Center

Active Organization

Guangzhou Women & Childrens Medical Center

Inactive Organization-

Drug Highest PhasePhase 2/3

First Approval Date-

Regulation-

Login to view timeline

The goal of this clinical trial is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in the treatment of Alport syndrome (AS) in a randomized, single-blind, placebo-controlled trial, to provide a clinical basis for the development of stem cell products for the treatment of AS, and to further clarify the therapeutic effect of hUC-MSC in the treatment of AS.

Start Date01 Jan 2025

Sponsor / Collaborator

Guangzhou Women & Childrens Medical Center

100 Clinical Results associated with Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center)

Login to view more data

100 Translational Medicine associated with Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center)

Login to view more data

100 Patents (Medical) associated with Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center)

Login to view more data

100 Deals associated with Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center)

Login to view more data